Anisindione Market By Strategic Analysis 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Anisindione Market
Anisindione Market Analysis: By Application(Anticoagulant, Protein Hydrolysis and Others) and By Geography (Europe, APAC, North America and Rest of the World) – With Forecast (2016-2021)
Report Code : CMR 0335
Updated Date: 22 January, 2016  
2

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Customization Options
1. Anisindione – Market Overview
2. Executive Summary
3. Anisindione Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Anisindione – Market Forces
   4.1. Drivers
      4.1.1. Increasing global instances for arterial and venous thrombosis
      4.1.2. Globally increasing adoption of protease enzymes
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Anisindione – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Anisindione Market - By Application
   6.1. Anticoagulant
   6.2. Protein Hydrolysis
   6.3. Others
7. Anisindione Market - By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Anisindione – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles
   9.1. Company 1
   9.2. Company 2
   9.3. Company 3
   9.4. Company 4
   9.5. Company 5
   9.6. Company 6
   9.7. Company 7
   9.8. Company 8
   9.9. Company 9
   9.10. Company 10
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Anisindione also know with the brand name Miradon, is an artificial anticoagulant and a derivative of indanedione. Anisindione helps in preventing the formation of active procoagulation factors II, VII, IX, and X, as well as the anticoagulant proteins C and S, in the liver by reducing the growth of the vitamin K–mediated gamma-carboxylation of precursor proteins. Anisindione is used for anticoagulant or antithrombotic drugs to cure thrombosis which is caused due to smoking, obesity, pregnancy, medical and genetic conditions, blood vessel damage, and inactivity among others. Anisindione aids in reducing thrombus formation and helps in curing the body’s abnormal blood.

This report identifies the anisindione market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to anisindione market.

Anisindione Market

Globally North America dominated the market for anisindione in 2015 due to higher usage of anisindione as an anticoagulant in medical science along with applications in protein synthesis. North America was followed by Europe and Asia-Pacific as the second and third largest markets respectively for anisindione in 2015. Asia-Pacific is expected to be the fastest growing market for the anisindione during the period of study due to increasing demand for protein hydrolysis enzymes in major emerging economies in the region coupled with increasing population in the region which is expected to increase in demand for anticoagulant drugs during the period of study.

This report on global anisindione is segmented on the basis of various applications of anisindione and market size in various geographical regions:
  • On the basis of applications of anisindione this report classified as follows covering all major applications of anisindione: Anticoagulant, Protein Hydrolysis and Others
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for anisindione in each of the region.

This report identifies all the major companies operating in the global anisindione market. Some of the major companies’ profiles in detail are as follows:
  • Aimpow. 
  • Toronto Research Chemicals Inc. 
  • Santacruz Biotechnology   
  • Schering Plough corp
  • Bayer Schering Pharma
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll